We provide a summary of the presentations made at the recent Euro-PDT annual Congress. Funding: Galderma.
INTRODUCTION
This year the conference was held again in Barcelona, Spain. Around 250 participants from Europe, but also Brazil, Canada and Singapore attended the two-day meeting which this year mainly focused on the new development and introduction of daylight-mediated photodynamic therapy (DL-PDT) in dermatologic therapy.
place as an accepted treatment procedure not only for the treatment of non-melanoma skin cancer (NMSC) including lymphomas but also for other indications like acne, skin rejuvenation, skin infections and other inflammatory disorders.
Prof. Yolanda
Gilaberte, Huesca, Spain, the Congress President, reflected on the tradition of the Annual EURO-PDT Meeting that permits researchers and clinicians from different countries get the opportunity not only to learn but also to interact and exchange knowledge and experience in the field of PDT (Fig. 1 ).
Plenary Session I: Epidemiology, Diagnosis and Consensus
The first plenary session focused on the (Fig. 2) . DL-PDT is suitable for patients with AK on face and scalp, lesion severity should be grade I or II AKs or actinic field damage. Although there was no complete clearance of the lesions, clinical and cosmetic improvement was achieved. The second prize was awarded to Yik Weng Yew from Singapore. His group treated truncal acne in 15 patients with 5% aminolevulinic acid for 3 h under occlusion, followed by illumination with red light (37 J/ cm 2 ) in a single session. 12 weeks later, a 64% reduction of inflammatory and 24% of non-inflammatory lesions was still present. The first prize also went to Spain, Dr.
García-Malinis from Huesca used MAL-PDT
for 43 patients with chondrodermatitis nodularis helicis (Fig. 3) . Around 74% of 
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